SCHEMBL1091393

SCHEMBL1091393

c1ccc2c(c1)CCN(c1nc(NCCCN3CCCC3)nc3ccccc13)C2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 6/20 0.54
▸ MRGPRX1 Q96LB2 1/20 0.49
▸ HRH2 P25021 1/20 0.49
▸ HRH1 P35367 1/20 0.49
▸ ACP1 P24666 3/20 0.48
▸ GBA1 P04062 1/20 0.47
▸ GRIN2D O15399 1/20 0.46
▸ GRIN3B O60391 1/20 0.46
▸ GRIN1 Q05586 1/20 0.46
▸ GRIN2A Q12879 1/20 0.46
▸ GRIN2B Q13224 1/20 0.46
▸ GRIN2C Q14957 1/20 0.46
▸ GRIN3A Q8TCU5 1/20 0.46
▸ BCHE P06276 1/20 0.46
▸ ACHE P22303 1/20 0.46
▸ TLR9 Q9NR96 1/20 0.46
▸ TLR7 Q9NYK1 1/20 0.46
▸ TUBB4A P04350 1/20 0.45
▸ TUBB P07437 1/20 0.45
▸ TUBA3C P0DPH7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1089853 0.94 MRGPRX1 (0.51) HRH3MRGPRX1ACP1GBA1GRIN2D
SCHEMBL1089123 0.93 MRGPRX1 (0.50) HRH3MRGPRX1HRH2HRH1ACP1
SCHEMBL1091105 0.91 KDM4E (0.57) HRH3ACP1GBA1BCHEACHE
SCHEMBL1090556 0.87 HRH3 (0.63) HRH3MRGPRX1HRH2HRH1ACP1
SCHEMBL1090472 0.86 HRH3 (0.65) HRH3MRGPRX1HRH2HRH1ACP1
SCHEMBL1088939 0.86 HRH3 (0.65) HRH3MRGPRX1HRH2HRH1ACP1
SCHEMBL1088872 0.86 HRH3 (0.65) HRH3MRGPRX1HRH2HRH1ACP1
SCHEMBL1091266 0.85 SLC2A1 (0.62) HRH3MRGPRX1GBA1GRIN2DGRIN3B
SCHEMBL1091992 0.84 KMT2A (0.52) ACP1GBA1BCHEACHETLR9
SCHEMBL2955070 0.83 KDM1A (0.49) HRH3MRGPRX1HRH2HRH1GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 — — US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 — — US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 — — US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 — — US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 — — US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 HRH3 94/4885MRGPRX1 237/4885HRH2 261/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 HRH3 94/4885MRGPRX1 237/4885HRH2 261/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 HRH3 94/4885MRGPRX1 237/4885HRH2 261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback